找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: New Drug Development; An Introduction to C J. Rick Turner Book 2010Latest edition Springer Science+Business Media, LLC 2010 Clinical.Develo

[復(fù)制鏈接]
樓主: microbe
11#
發(fā)表于 2025-3-23 13:31:22 | 只看該作者
12#
發(fā)表于 2025-3-23 15:11:59 | 只看該作者
introduction to statistics and illustrates its important rolNew Drug Development: Second Edition provides an overview of the design concepts and statistical practices involved in therapeutic drug development. This wide spectrum of activities begins with identifying a potentially useful drug candidat
13#
發(fā)表于 2025-3-23 20:27:58 | 只看該作者
Book 2010Latest editionhis wide spectrum of activities begins with identifying a potentially useful drug candidate that can perhaps be used in the treatment or prevention of a condition of clinical concern, and ends with marketing approval being granted by one or more regulatory agencies. In between, it includes drug mole
14#
發(fā)表于 2025-3-24 01:44:50 | 只看該作者
http://image.papertrans.cn/n/image/665160.jpg
15#
發(fā)表于 2025-3-24 04:20:31 | 只看該作者
16#
發(fā)表于 2025-3-24 09:44:42 | 只看該作者
Statistical Analysis,As noted in Chapter 1, Statistics can be thought of as an integrated discipline that includes several steps:
17#
發(fā)表于 2025-3-24 12:14:50 | 只看該作者
18#
發(fā)表于 2025-3-24 17:03:03 | 只看該作者
Nonclinical Research,egulatory governance, and reports of them are included in regulatory submissions requesting marketing approval. Three areas of investigation are considered here: pharmacokinetics, pharmacology, and toxicology. The scientific rationale of the studies is addressed, along with a summary of appropriate regulatory guidance.
19#
發(fā)表于 2025-3-24 19:38:31 | 只看該作者
Designing Clinical Trials, design, conduct, and analysis impose artificial divisions on a process whose very nature is interactive and integrative. However, there is benefit in looking at components separately, since discussions can temporarily focus on one or two of them before illustrating the interrelatedness of all three. This chapter focuses on study design.
20#
發(fā)表于 2025-3-25 01:08:39 | 只看該作者
Efficacy Assessment,g approval, that is, it needs to have a favorable benefit–risk profile. Therapeutic benefit, operationalized as efficacy, is evaluated in therapeutic exploratory and therapeutic confirmatory trials, trials in which the subjects have the disease or condition of biological concern.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 13:55
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
鹤庆县| 融水| 洞头县| 乾安县| 广元市| 绥化市| 灵寿县| 项城市| 博客| 长春市| 丹寨县| 汉川市| 乐业县| 微山县| 古蔺县| 正阳县| 花莲市| 黄石市| 泽普县| 黔西县| 中牟县| 渑池县| 郸城县| 托克托县| 北流市| 张家川| 嫩江县| 延边| 开封县| 蓝山县| 德江县| 昌吉市| 台安县| 长武县| 明水县| 萨迦县| 比如县| 辉县市| 凤翔县| 马山县| 孝昌县|